DEFINITIVE CONTRACT
Active75F40126C00069
Department of Health and Human Services › Food and Drug Administration › FDA OFFICE OF ACQ GRANT SVCS
$634.6K
obligated · signed 3 weeks ago
BAA CONTRACT- FY26C2AP9 ADVANCED CMC INDEX AND INTELLIGENCE PLATFORM FOR DRUG QUALITY CONTROL, SHORTAGE PREDICTION, AND STRATEGIC RESHORING
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2027
with all options
Loading status
This contract is likely in the recompete window
Ends with all options: Sep 29, 2027
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC
Contract 75F40126C00069
UEI
RKVKGV1CJDB8
Parent Company
NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC
Capabilities & Certifications
Headquarters Location
Congressional District: 05
Current Obligation
$634,642
Base + Exercised Options
$634,642
Total Ceiling Value
$634,642
Contract Type
FIRM FIXED PRICE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSC
GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Place of Performance
Congressional District: 05
Awarding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Funding Agency
Top-tier agency
Food and Drug Administration
Sub-tier agency
FDA OFFICE OF ACQ GRANT SVCS
Office
Solicitation procedures, competition exceptions, labor standards and account totals.